HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.

AbstractOBJECTIVES:
Analyses of mechanical circulatory support (MCS) in pediatric heart surgery have primarily focused on single-center outcomes or narrow applications. We describe the patterns of use, patient characteristics, and MCS-associated outcomes across a large multicenter cohort.
METHODS:
Patients (aged <18 years) in the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database (2000-2010) were included. The characteristics and outcomes of those receiving postoperative MCS were described, and bayesian hierarchical models were used to examine variations in the adjusted MCS rates across institutions.
RESULTS:
Of 96,596 operations (80 centers), MCS was used in 2.4%. The MCS patients were younger (13 vs 195 days, P < .0001) and more often had STS-defined preoperative risk factors (57.2% vs 32.7%, P < .0001). The operations with the greatest MCS rates included the Norwood procedure (17%) and complex biventricular repairs (arterial switch, ventricular septal defect, and arch repair [14%]). More than one half of the MCS patients did not survive to hospital discharge (53.2% vs 2.9% of non-MCS patients; P < .0001). MCS-associated mortality was greatest for truncus arteriosus and Ross-Konno operations (both 71%). The hospital-level MCS rates adjusted for patient characteristics and case mix varied by 15-fold across institutions, with both high- and low-volume hospitals having substantial variation in MCS rates.
CONCLUSIONS:
Perioperative MCS use varied widely across centers. The MCS rates were greatest overall for the Norwood procedure and complex biventricular repairs. Although MCS can be a life-saving therapy, more than one half of MCS patients will not survive to hospital discharge, with mortality >70% for some operations. Future studies aimed at better understanding the appropriate indications, optimal timing, and management of MCS could help to reduce the variation in MCS use across hospitals and improve outcomes.
AuthorsChristopher E Mascio, Erle H Austin 3rd, Jeffrey P Jacobs, Marshall L Jacobs, Amelia S Wallace, Xia He, Sara K Pasquali
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 147 Issue 2 Pg. 658-64: discussion 664-5 (Feb 2014) ISSN: 1097-685X [Electronic] United States
PMID24246548 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Topics
  • Assisted Circulation (adverse effects, mortality, trends)
  • Bayes Theorem
  • Cardiac Surgical Procedures (adverse effects, mortality, trends)
  • Child, Preschool
  • Databases, Factual
  • Female
  • Heart Defects, Congenital (mortality, surgery)
  • Hospitals, High-Volume
  • Hospitals, Low-Volume
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Perioperative Care
  • Practice Patterns, Physicians' (trends)
  • Risk Factors
  • Societies, Medical
  • Time Factors
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: